Gsa Capital Partners LLP Protara Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 93,113 shares of TARA stock, worth $310,066. This represents 0.02% of its overall portfolio holdings.
Number of Shares
93,113
Previous 54,857
69.74%
Holding current value
$310,066
Previous $234,000
20.51%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
28.4MCall Options Held
365KPut Options Held
108K-
Janus Henderson Group PLC London, X03.79MShares$12.6 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.4MShares$11.3 Million0.3% of portfolio
-
Blackstone Inc New York, NY1.74MShares$5.81 Million0.03% of portfolio
-
Opaleye Management Inc. Boston, MA1.73MShares$5.76 Million2.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA1.67MShares$5.55 Million12.25% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $37.5M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...